Biomarkers · Coagulation
von Willebrand Factor (vWF)
Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
vWF and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Published risk of death2.00×vWf in the upper tertile (>1.56 IU/mL) (95% CI 1.10–3.50) · Hoorn Study (Netherlands): age-, sex- and glucose-tolerance-stratified sample of a population-based cohort aged 50-75 y
Sources
- Risk curve: Jager 1999 (PMID 10591689): all-cause RR 2.0 (1.1-3.5) vWf in the upper tertile (>1.56 IU/mL); reference group not reported. Scaled to published population values.
- Jager et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arteriosclerosis, thrombosis, and vascular biology. 1999;19:3071-8.
Map von Willebrand Factor (vWF) against another biomarker.
Related markers: Angiopoietin-2 · Coagulation Factor VIII · Coagulation Factor VIIc · D-dimer · Plasma Viscosity · Plasminogen Activator Inhibitor-1 (PAI-1) · Soluble ICAM-1 (sICAM-1)